Runxiang Yang

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Jie Wang, Caicun Zhou, Wenxiu Yao et al. · The Lancet Oncology · 2022 · 361 citations

Oncology, Pharmacology, Bronchial Neoplasm +5

Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

Ying Cheng, Jianhua Chen, Wei Zhang et al. · Nature Medicine · 2024 · 100 citations · Full text

Medicine, Interim Os Analysis, Immunology +11

FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth

Wenxia Wei, Baifu Qin, Weijie Wen et al. · Signal Transduction and Targeted Therapy · 2023 · 92 citations · Full text

Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells

Lincan Duan, Hongmei Shen, Guangqiang Zhao et al. · Biochemical and Biophysical Research Communications · 2014 · 91 citations

Nanomedicine, Oncology, Polymer-drug Conjugate +10

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Meiqi Shi, Hai‐Yan Tu, Cheng Huang et al. · Annals of Oncology · 2020 · 70 citations · Full text